Literature DB >> 1763324

Linkage of faulty major histocompatibility complex class I to autoimmune diabetes.

D Faustman1, X P Li, H Y Lin, Y E Fu, G Eisenbarth, J Avruch, J Guo.   

Abstract

Pancreatic islet cells are the targets of an autoimmune response in type I diabetes. In the nonobese diabetic (NOD) mouse model of autoimmune diabetes, expression of major histocompatibility complex (MHC) class I proteins was inversely correlated with diabetes; in this mouse a mutation in the MHC class II-linked gene for the putative MHC class I peptide transporter was also present. Mice deficient in MHC class I expression because they do not produce beta 2-microglobulin also developed late onset autoimmune diabetes. In cells from humans with type I diabetes expression of MHC class I was decreased; subsets of prediabetics categorized as most likely to become hyperglycemic also had low MHC class I. T cell responses to self antigens are faulty in diabetics. In sets of genetically identical twins that are discordant for diabetes, the defect appeared to reside with the antigen presenting cell. Thus, a lack of surface MHC class I protein is associated with autoimmune diabetes; the concomitant defect in antigen presentation may impair the development of self tolerance, which could result in autoimmune disease.

Entities:  

Mesh:

Year:  1991        PMID: 1763324     DOI: 10.1126/science.1763324

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  46 in total

1.  Characterization of a novel functional protein in the pancreatic islet: islet homeostasis protein regulation of glucagon synthesis in α cells.

Authors:  Seh-Hoon Oh; Houda Darwiche; Jae-Hyoung Cho; Thomas Shupe; Bryon E Petersen
Journal:  Pancreas       Date:  2012-01       Impact factor: 3.327

2.  Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.

Authors:  S Ryu; S Kodama; K Ryu; D A Schoenfeld; D L Faustman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 3.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

4.  Allelic variants of the human putative peptide transporter involved in antigen processing.

Authors:  M Colonna; M Bresnahan; S Bahram; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

5.  Reversal of Sjogren's-like syndrome in non-obese diabetic mice.

Authors:  Simon D Tran; Shohta Kodama; Beatrijs M Lodde; Ildiko Szalayova; Sharon Key; Saeed Khalili; Denise L Faustman; Eva Mezey
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

6.  Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteasome gene (Lmp-2).

Authors:  P Zhou; H Cao; M Smart; C David
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Cloning and genomic characterization of LST1: a new gene in the human TNF region.

Authors:  I Holzinger; A de Baey; G Messer; G Kick; H Zwierzina; E H Weiss
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Fennessy; K Metcalfe; G A Hitman; M Niven; P A Biro; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

9.  Transporters from H-2b, H-2d, H-2s, H-2k, and H-2g7 (NOD/Lt) haplotype translocate similar sets of peptides.

Authors:  T N Schumacher; D V Kantesaria; D V Serreze; D C Roopenian; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.

Authors:  Y Fu; D M Nathan; F Li; X Li; D L Faustman
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.